Novartis AG (FRA:NOTA)

Market Cap	219.36B
Revenue (ttm)	46.99B
Net Income (ttm)	11.63B
Shares Out	n/a
EPS (ttm)	5.83
PE Ratio	18.87
Forward PE	14.87
Dividend	3.10 (2.84%)
Ex-Dividend Date	Mar 12, 2025

Volume	13
Average Volume	53
Open	111.00
Previous Close	110.50
Day's Range	111.00 - 111.00
52-Week Range	88.20 - 115.50
Beta	n/a
RSI	55.03
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NOTA

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD